clinical trials

NEW YORK — September 28, 2026 Pfizer Inc. announced that it will present data from 45 company-sponsored, investigator-sponsored and...

Durham, North Carolina, U.S., September 24, 2026 Clywedog Therapeutics has announced final results from its Phase 1b clinical study...

Pleasanton, California, U.S., September 24, 2026 Veeva Systems Inc. has announced the Veeva Study Builder Agent, a new artificial...

Indianapolis, Indiana, U.S., September 24, 2026 Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval...

ORLANDO, Fla. — September 23, 2026 Oracle announced expanded capabilities in Oracle Life Sciences Data Intelligence, combining real-world data,...

Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...

Berlin, Germany, September 17, 2026 Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia™ (finerenone)...

Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...

Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...

Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...